ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Fatbradpitt
|
31 |
7.9K |
10 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
31
|
7.9K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Successful OrthoATI clinical trial
|
|
Fatbradpitt
|
47 |
11K |
8 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
47
|
11K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Fatbradpitt
|
1.3K |
545K |
14 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
545K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Fatbradpitt
|
1.3K |
545K |
11 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
545K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Movement at the Station
|
|
Fatbradpitt
|
71 |
21K |
19 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
71
|
21K
|
19
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Change of Director's Interest Notice LL
|
|
Fatbradpitt
|
20 |
5.8K |
5 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
20
|
5.8K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Bio Horizons is marketing Sriate+ directly on its homepage
|
|
Fatbradpitt
|
74 |
27K |
11 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
74
|
27K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Gains Australian Reimbursement
|
|
Fatbradpitt
|
62 |
18K |
7 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
62
|
18K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Gains Australian Reimbursement
|
|
Fatbradpitt
|
62 |
18K |
5 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
62
|
18K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Rotator Cuff Study Success With Cross-Over Patients
|
|
Fatbradpitt
|
81 |
28K |
14 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
81
|
28K
|
14
|
|
ASX - By Stock
|
OCC |
Re:
Ann: First orders for Striate and Remplir
|
|
Fatbradpitt
|
37 |
12K |
12 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
37
|
12K
|
12
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appointment of Exclusive Australian Distributor for Remplir
|
|
Fatbradpitt
|
52 |
17K |
7 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
52
|
17K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appointment of Exclusive Australian Distributor for Remplir
|
|
Fatbradpitt
|
52 |
17K |
10 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
52
|
17K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Fatbradpitt
|
42 |
15K |
20 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
42
|
15K
|
20
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Final Report and Annual Report to Shareholders
|
|
Fatbradpitt
|
8 |
4.1K |
5 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
8
|
4.1K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Fatbradpitt
|
496 |
153K |
7 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
496
|
153K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Fatbradpitt
|
1.6K |
467K |
17 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
1.6K
|
467K
|
17
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Fatbradpitt
|
496 |
153K |
0 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
496
|
153K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Fatbradpitt
|
496 |
153K |
15 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
496
|
153K
|
15
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate Global License and Distribution Agreement Update
|
|
Fatbradpitt
|
69 |
22K |
7 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
69
|
22K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Fatbradpitt
|
1.6K |
467K |
3 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
1.6K
|
467K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Fatbradpitt
|
298 |
80K |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
298
|
80K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Fatbradpitt
|
298 |
80K |
7 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
298
|
80K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Fatbradpitt
|
298 |
80K |
7 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
298
|
80K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Fatbradpitt
|
298 |
80K |
6 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
298
|
80K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Fatbradpitt
|
298 |
80K |
2 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
298
|
80K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Fatbradpitt
|
298 |
80K |
10 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
298
|
80K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Final Data Readout for Orthocells Nerve Reconstruction Study
|
|
Fatbradpitt
|
59 |
19K |
4 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
59
|
19K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Final Data Readout for Orthocells Nerve Reconstruction Study
|
|
Fatbradpitt
|
59 |
19K |
3 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
59
|
19K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Final Data Readout for Orthocells Nerve Reconstruction Study
|
|
Fatbradpitt
|
59 |
19K |
3 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
59
|
19K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Final Data Readout for Orthocells Nerve Reconstruction Study
|
|
Fatbradpitt
|
59 |
19K |
16 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
59
|
19K
|
16
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Fatbradpitt
|
25 |
10K |
4 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
25
|
10K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval for Remplir Nerve Repair Device
|
|
Fatbradpitt
|
111 |
38K |
6 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
111
|
38K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Fatbradpitt
|
106 |
33K |
0 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
106
|
33K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Fatbradpitt
|
106 |
33K |
2 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
106
|
33K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Pause in Trading
|
|
Fatbradpitt
|
29 |
6.7K |
5 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
29
|
6.7K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Pause in Trading
|
|
Fatbradpitt
|
29 |
6.7K |
2 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
29
|
6.7K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Fatbradpitt
|
106 |
33K |
2 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
106
|
33K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Fatbradpitt
|
106 |
33K |
9 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
106
|
33K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Pause in Trading
|
|
Fatbradpitt
|
29 |
6.7K |
3 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
29
|
6.7K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Pause in Trading
|
|
Fatbradpitt
|
29 |
6.7K |
3 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
29
|
6.7K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate US Market Entry Update
|
|
Fatbradpitt
|
39 |
10K |
9 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
39
|
10K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate US Market Entry Update
|
|
Fatbradpitt
|
39 |
10K |
6 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
39
|
10K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Fatbradpitt
|
496 |
153K |
4 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
496
|
153K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Fatbradpitt
|
496 |
153K |
7 |
11/12/21 |
11/12/21 |
ASX - By Stock
|
496
|
153K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Tendon Clinical Study Success
|
|
Fatbradpitt
|
241 |
62K |
7 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
241
|
62K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Tendon Clinical Study Success
|
|
Fatbradpitt
|
241 |
62K |
8 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
241
|
62K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Fatbradpitt
|
67 |
16K |
1 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
67
|
16K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Fatbradpitt
|
67 |
16K |
11 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
67
|
16K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Ortho-ATI Shoulder Tendon Study Database Lock
|
|
Fatbradpitt
|
161 |
38K |
2 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
161
|
38K
|
2
|
|